Novo Nordisk Current Ratio 2006-2019 | NVO

Current and historical current ratio for Novo Nordisk (NVO) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Novo Nordisk current ratio for the three months ending June 30, 2019 was 1.04.
Novo Nordisk Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $8.84B $8.52B 1.04
2019-03-31 $8.03B $8.33B 0.96
2018-12-31 $9.03B $8.28B 1.09
2018-09-30 $8.45B $7.71B 1.10
2018-06-30 $9.21B $7.87B 1.17
2018-03-31 $8.24B $7.29B 1.13
2017-12-31 $9.13B $7.15B 1.28
2017-09-30 $9.02B $7.13B 1.27
2017-06-30 $8.72B $6.48B 1.35
2017-03-31 $7.98B $7.01B 1.14
2016-12-31 $8.88B $7.05B 1.26
2016-09-30 $7.74B $6.24B 1.24
2016-06-30 $7.99B $6.31B 1.27
2016-03-31 $6.86B $6.08B 1.13
2015-12-31 $8.21B $6.08B 1.35
2015-09-30 $7.68B $5.74B 1.34
2015-06-30 $7.02B $5.72B 1.23
2015-03-31 $6.59B $6.37B 1.04
2014-12-31 $8.25B $6.01B 1.37
2014-09-30 $7.33B $5.35B 1.37
2014-06-30 $6.29B $4.37B 1.44
2014-03-31 $6.34B $4.85B 1.31
2013-12-31 $7.49B $4.31B 1.74
2013-09-30 $7.27B $4.56B 1.59
2013-06-30 $6.40B $4.45B 1.44
2013-03-31 $6.34B $4.54B 1.40
2012-12-31 $6.94B $3.74B 1.86
2012-09-30 $6.87B $4.41B 1.56
2012-06-30 $6.21B $4.12B 1.51
2012-03-31 $6.41B $3.88B 1.65
2011-12-31 $7.40B $3.88B 1.91
2011-09-30 $7.37B $3.87B 1.91
2011-06-30 $7.31B $3.59B 2.04
2011-03-31 $6.51B $3.35B 1.94
2010-12-31 $6.65B $3.29B 2.02
2010-09-30 $5.87B $2.93B 2.00
2010-06-30 $5.78B $3.13B 1.85
2010-03-31 $5.84B $2.89B 2.02
2009-12-31 $6.12B $2.51B 2.44
2009-09-30 $5.95B $2.48B 2.40
2009-06-30 $5.44B $2.28B 2.38
2009-03-31 $5.02B $2.48B 2.03
2008-12-31 $5.73B $2.55B 2.24
2008-09-30 $5.48B $2.49B 2.20
2008-06-30 $5.51B $2.32B 2.38
2008-03-31 $4.98B $2.33B 2.13
2007-12-31 $4.47B $1.96B 2.28
2007-09-30 $4.30B $1.99B 2.16
2007-06-30 $4.15B $1.91B 2.17
2007-03-31 $3.68B $1.88B 1.97
2006-12-31 $3.50B $1.71B 2.05
2006-09-30 $3.51B $1.96B 1.79
2006-06-30 $3.41B $1.72B 1.99
2006-03-31 $3.04B $1.69B 1.80
2005-12-31 $3.27B $1.77B 1.85
2005-09-30 $2.94B $1.51B 1.95
2005-06-30 $2.72B $1.45B 1.87
2005-03-31 $2.84B $1.29B 2.19
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $124.367B $17.724B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $337.021B 14.56
Roche Holding AG (RHHBY) Switzerland $252.093B 0.00
Merck (MRK) United States $216.813B 17.83
Pfizer (PFE) United States $201.662B 11.88
Novartis AG (NVS) Switzerland $199.112B 17.14
Sanofi (SNY) France $115.616B 14.21
AstraZeneca (AZN) United Kingdom $115.105B 22.27
AbbVie (ABBV) United States $113.045B 9.06
GlaxoSmithKline (GSK) United Kingdom $106.079B 13.33
Eli Lilly (LLY) United States $104.885B 19.58
Bristol-Myers Squibb (BMY) United States $86.745B 12.30
Bayer (BAYRY) Germany $67.852B 9.89
H Lundbeck (HLUYY) Denmark $6.592B 9.51